Trevor, Stewart, Burton & Jacobsen’s AbbVie ABBV Stock Holding History

Trevor, Stewart, Burton & Jacobsen’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-3,620	Closed	-$237K	–	39
2014 Q4	$237K	Sell	3,620 -7,650	-68%	-$482K	0.19%	40
2014 Q3	$651K	Sell	11,270 -1,000	-8%	-$55.5K	0.42%	36
2014 Q2	$693K	Sell	12,270 -21,825	-64%	-$1.14M	0.36%	41
2014 Q1	$1.75M	Sell	34,095 -67,289	-66%	-$3.4M	0.85%	28
2013 Q4	$5.35M	Sell	101,384 -36,230	-26%	-$1.78M	2.45%	22
2013 Q3	$6.16M	Sell	137,614 -1,620	-1%	-$71.8K	3.18%	14
2013 Q2	$5.75M	Buy	+139,234	New	+$6.09M	3.07%	19

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Trevor, Stewart, Burton & Jacobsen's ABBV Position: Q1 2015 in Review

Trevor, Stewart, Burton & Jacobsen sold out of AbbVie (ABBV) in Q1 2015, closing a stake of 3,620 shares — an estimated $237K sold.

Trevor, Stewart, Burton & Jacobsen first reported a position in ABBV in Q2 2013 and held it in 7 quarters. The position peaked at $6.16M in Q3 2013. 1,601 funds tracked by Wall St. Rank hold ABBV as of Q1 2015.

Trevor, Stewart, Burton & Jacobsen reported no remaining AbbVie position as of Q1 2015 after selling out during the quarter.
Trevor, Stewart, Burton & Jacobsen sold 3,620 AbbVie shares in Q1 2015, an estimated $237K.
Trevor, Stewart, Burton & Jacobsen first reported a position in AbbVie in Q2 2013 and held it in 7 quarters.
Trevor, Stewart, Burton & Jacobsen's AbbVie position peaked at $6.16M in Q3 2013.
1,601 funds tracked by Wall St. Rank held AbbVie as of Q1 2015.

Based on Trevor, Stewart, Burton & Jacobsen's 13F filing for Q1 2015, filed 13 May 2015.